Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
32.70
-1.54 (-4.50%)
At close: Aug 24, 2026, 4:00 PM EDT
33.45
+0.75 (2.29%)
After-hours: Aug 24, 2026, 4:33 PM EDT

Alamar Biosciences Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Alamar Biosciences stock has a consensus rating of "Buy" and an average price target of $33.4. The average 1-year stock price forecast is 2.14% higher than the current stock price, while the lowest is $31 (-5.20%) and the highest is $35 (+7.03%).

Price Target: $33.4 (+2.14%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$31$33.4$34$35
Change-5.20%+2.14%+3.98%+7.03%

Analyst Ratings

The average analyst rating for Alamar Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26
Strong Buy3333
Buy1111
Hold1111
Sell0000
Strong Sell0000
Total5555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Hold
Reiterates
$30$31
HoldReiterates$30$31-5.20%Aug 11, 2026
J.P. Morgan
J.P. Morgan
Buy
Reiterates
$32$35
BuyReiterates$32$35+7.03%Aug 11, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$28$32
BuyMaintains$28$32-2.14%Aug 11, 2026
TD Cowen
TD Cowen
Buy
Maintains
$30$34
BuyMaintains$30$34+3.98%Jul 15, 2026
Leerink Partners
Leerink Partners
Buy
Initiates
$35
BuyInitiates$35+7.03%May 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
118.58M
from 74.21M
Increased by 59.79%
Revenue Next Year
165.71M
from 118.58M
Increased by 39.75%
EPS This Year
-1.16
EPS Next Year
-0.54
from -1.16
Fiscal YearFY 2024FY 2025FY 2026
Period EndingDec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
25.14M74.21M118.58M
Revenue Growth
-195.17%59.79%
Gross Profit
8.61M41.71M67.71M
Gross Margin
34.23%56.20%57.10%
Operating Income
-49.57M-31.33M-58.86M
Net Income
-47.07M-29.82M-64.94M
EPS
---1.16
Free Cash Flow
--49.70M-81.00M
No. Analysts
--5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High119.4M
Avg118.6M
Low117.8M

Revenue Growth

Revenue Growth202620272028
High
60.8%
Avg
59.8%
Low
58.7%

EPS Forecast

EPS202620272028
High-0.86
Avg-1.16
Low-1.31

EPS Growth

EPS Growth20272028
High-
Avg-
Low-